Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of CinnaGen recombinant human growth hormone and Novo Nordisk growth hormone in children with growth hormone deficiency
IRCT201409064920N5Phase 3Completed
- Sponsor
- CinnaGen
- Start
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of somatropin in idiopathic growth hormone deficiency (I-GHD) (2 arms), sponsored by CinnaGen. Started Mar 2016; status: completed.
02
Drugs
somatropin
03
Conditions
idiopathic growth hormone deficiency (I-GHD)
Beyond the preview
Go deeper on IRCT201409064920N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201409064920N5.